BARCLAYS PLC - ACLARIS THERAPEUTICS INC ownership

ACLARIS THERAPEUTICS INC's ticker is ACRS and the CUSIP is 00461U105. A total of 153 filers reported holding ACLARIS THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ACLARIS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,603
+81.1%
234,150
+174.2%
0.00%0.0%
Q2 2023$885
-42.0%
85,389
-54.7%
0.00%
Q1 2023$1,526
+126.4%
188,690
+340.8%
0.00%
Q4 2022$674
-99.7%
42,810
+156.2%
0.00%
Q3 2022$263,000
-14.3%
16,707
-24.0%
0.00%
Q2 2022$307,000
-70.5%
21,969
-63.5%
0.00%
-100.0%
Q1 2022$1,039,000
-64.4%
60,256
-70.0%
0.00%0.0%
Q4 2021$2,922,000
+223.6%
201,036
+300.7%
0.00%
Q3 2021$903,000
+340.5%
50,169
+326.4%
0.00%
Q2 2021$205,00011,767
+65272.2%
0.00%
Q1 2021$0180.0%0.00%
Q4 2020$0180.0%0.00%
Q3 2020$0
-100.0%
18
-99.8%
0.00%
Q2 2020$13,000
+18.2%
8,294
-21.1%
0.00%
Q1 2020$11,000
-93.1%
10,516
-87.5%
0.00%
Q4 2019$159,000
+783.3%
83,853
+389.9%
0.00%
Q3 2019$18,000
-64.0%
17,118
-25.6%
0.00%
Q2 2019$50,000
-20.6%
23,015
+119.5%
0.00%
Q1 2019$63,000
-64.6%
10,483
-14.4%
0.00%
Q3 2018$178,000
+356.4%
12,243
+523.4%
0.00%
Q2 2018$39,000
-64.9%
1,964
-69.2%
0.00%
Q1 2018$111,000
-0.9%
6,378
+40.7%
0.00%
Q4 2017$112,000
-41.7%
4,532
-39.2%
0.00%
Q3 2017$192,000
+1180.0%
7,457
+1248.5%
0.00%
Q2 2017$15,000
-91.0%
553
-90.1%
0.00%
Q1 2017$167,000
+15.2%
5,608
+4.8%
0.00%
Q4 2016$145,000
+3525.0%
5,350
+3396.7%
0.00%
Q3 2016$4,000
-84.6%
153
-84.7%
0.00%
Q4 2015$26,0001,0000.00%
Other shareholders
ACLARIS THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 441,000$833,0002.78%
MFN Partners Management, LP 4,000,000$7,560,0001.56%
Endurant Capital Management LP 2,055,069$3,884,0001.22%
Broadfin Capital, LLC 1,888,039$3,568,0000.48%
Aisling Capital Management LP 634,455$1,199,0000.46%
EcoR1 Capital, LLC 2,087,312$3,945,0000.36%
Sofinnova Investments, Inc. 1,911,573$3,613,0000.26%
Alambic Investment Management, L.P. 115,036$217,0000.18%
Parkman Healthcare Partners LLC 225,000$425,0000.12%
Rock Springs Capital Management LP 1,600,000$3,024,0000.10%
View complete list of ACLARIS THERAPEUTICS INC shareholders